AltPep
AltPep develops early detection tools and disease-modifying treatments for amyloid diseases, including neurodegenerative conditions and type 2 diabetes, by targeting toxic soluble oligomers. Its lead program focuses on identifying Alzheimer’s disease before symptoms appear and neutralizing the associated toxic oligomers. The organization aims to enable early screening and preventive intervention for these diseases.
Facts
- HQ
- Seattle, WA
- Sectors
- Biotechnology
- Founded
- 2019
- Type
- Corporation Seattle business license
- Employees
- 32
- Registered name
- AltPep Corporation Seattle business license
- Stage
- Series B
- Members see funding amounts. .
Is this your organization? Claim it
Members see AltPep's funding rounds, amounts and investors.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
People
-
Valerie Daggett Executive Officer, Director, Promoter, Founder and CEO